missing translation for 'onlineSavingsMsg'
Learn More
Learn More
MAP3K12 Antibody, Novus Biologicals™
Rabbit Polyclonal Antibody has been used in 6 publications
£186.00 - £447.00
Specifications
| Antigen | MAP3K12 |
|---|---|
| Dilution | Western Blot 1:500, ELISA 1:1000, Immunoprecipitation 1:200 |
| Applications | Immunoprecipitation, Western Blot, ELISA |
| Classification | Polyclonal |
| Conjugate | Unconjugated |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
18240132
|
Novus Biologicals
NBP1-46063-0.025MG |
0.025 mg |
£186.00
25µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
18203141
|
Novus Biologicals
NBP1-46063-0.05MG |
0.05 mg |
£330.00
0.05mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
18537382
|
Novus Biologicals
NBP1-46063-0.1mg |
0.1 mg |
£447.00
0.10mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
MAP3K12 Polyclonal specifically detects MAP3K12 in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunoprecipitation.Specifications
| MAP3K12 | |
| Immunoprecipitation, Western Blot, ELISA | |
| Unconjugated | |
| Rat, Mouse, Human | |
| DLKEC 2.7.11.25, Dual leucine zipper bearing kinase, EC 2.7.11, Leucine-zipper protein kinase, MAPK-upstream kinase, MEKK12, mitogen-activated protein kinase kinase kinase 12, Mixed lineage kinase, MUKdual leucine zipper kinase DLK, protein kinase MUK, ZPKleucine zipper protein kinase, ZPKP1 | |
| MAP3K12 | |
| IgG | |
| Specifically detects a unique epitope on MAP3K12. |
| Western Blot 1:500, ELISA 1:1000, Immunoprecipitation 1:200 | |
| Polyclonal | |
| Rabbit | |
| Q12852 | |
| 7786 | |
| Synthetic peptides corresponding to unique epitope on MAP3K12. The peptide sequence was selected from mid-region, amimo acids 270-320. This peptide was covalently modified post-synthetically to achieve desired antigenicity. | |
| Primary |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title